Mr. Anish More appointed as Managing Director for 3 years

Ceo Appointed ExternalManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹30.50

prior close

₹32.39

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+4.4% vs market

Other Financial Services peers, median of 86sector+0.0%+2.9% vs sector

On the reaction day the stock moved 4.4 pts more than Nifty Microcap 250 and 2.9 pts more than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.3

15m

-1.0

30m

-3.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9-1.6+4.4+0.0+2.9

Next day

+4.8-0.6+5.4-0.4+5.2

+1.6-0.8+2.5-1.0+2.6

+7.5-2.1+9.7-1.6+9.1

+6.4-2.1+8.5-1.7+8.1

+10.5-0.8+11.3-1.3+11.8

+7.2-3.8+11.0-2.2+9.4

15d

-9.0-6.9-2.1-3.7-5.3

—————

UpDownMarket · Nifty Microcap 250Sector · Other Financial Services peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nexus Surgical and Medicare shareholders approved Mr. Anish More (DIN 11070098) as Managing Director at the 35th AGM on 25 Sep 2026. The appointment runs for 3 years from 2 Sep 2026 to 1 Sep 2029. Remuneration is set at Rs 24 lakh per annum. He holds an M.S. from UC Riverside and a B.E. in Computer Engineering. He co-founded Saans AI, a healthcare tech venture, and is not related to any existing Director or KMP.

Likely market impact

External tech-background appointee as MD suggests possible shift toward healthcare technology; modest pay of Rs 24 lakh per annum signals cost discipline.